How to search

Enter a search term in the search box at the top of the page, and press the "search" button.

The system searches the fields: First name, surname, research interests,current institute, city, country and nationality. The number of results are displayed directly under the search box, and the term queried is highlighted in the text.

Under the Search box at the top of the page, you will see the number of search results found for any one search.

You can filter a search by using the left-hand menu. Filters can only be applied AFTER you have begun a search. To cancel one or more filters, simply close the relevant filter from the "Filters" box at the top of the search list. The Filters box only appears after you have selected a filter from the left-hand menu.

Close (X)

Filters:
  • Miller Group
 
About 4 results

  1. David Hulmes

    Current information Research Director, CNRS Institut de Biologie et Chimie des Protéines
    7 passage du Vercors     LYON, France E-mail Nationality: British
    EMBL information Postdoctoral Fellow Miller Group GR From 1976 to 1978 Biography Hide biography
    Biography: Degrees

    1969-1972 University of Wales (B.Sc., physics)
    1972-1975 University of Oxford (D.Phil., molecular biophysics)

    Previous positions

    1/76 - 3/78 EMBO/EMBL Fellow, European Molecular Biology Organisation, Grenoble Outstation, France.
    4/78 - 6/81 Assistant Professor, Developmental Biology Lab, Massachusetts General Hospital, Harvard Medical School, Boston, Mass, USA.
    7/81 - 9/85 Research Fellow, then MRC Senior Research Fellow, Department of Medical Biophysics, University of Manchester.
    10/85 - 9/90 Lecturer in Biochemistry, University of Edinburgh
    1/91 - 12/93 Wellcome Research Leave Fellow, Department of Biochemistry, University of Edinburgh.
    10/90 - 9/94 Senior Lecturer in Biochemistry, University of Edinburgh
    10/94 - 12/95 Reader, Department of Biochemistry, University of Edinburgh

  2. Andrew Miller

    Current information Secretary and Treasurer, The Carnegie Trust for the Universities of Scotland Andrew Carnegie House
    Pittencrieff Street     DUNFERMLINE, Fife, United Kingdom Nationality: British
    EMBL information Unit Coordinator Miller Group GR From 1975 to 1980

  3. Stephen Perkins

    Current information Professor, University College London Department of Structural and Molecular Biology, Division of Biosciences, Darwin Building, University College London, Gower St London, United Kingdom E-mail Nationality: British
    EMBL information Postdoctoral Fellow Miller Group GR From 11.1978 to 10.1981 Research interests: Complement, antibodies, neutron scattering, X-ray scattering, analytical ultracentrifugation, molecular modelling, surface plasmon resonance Biography Hide biography
    Biography: Pembroke College, Oxford University, 1969-1973.
    First Class Honours degree in Chemistry (1973), with Biochemistry Supplementary Subject.

    Pembroke College, Oxford University, 1973-1975.
    Senior Scholarship from Wolfson College, Oxford University, 1975-1976.
    Doctor of Philosophy in Molecular Biophysics (1977).


    Research Positions: 1976-1986

    1976-1978. EMBO Fellowship at the ETH-Zürich, Switzerland (2 years)
    1978-1981. EMBL Fellowship at the EMBL in Grenoble, France (3 years)
    1981-1983. Research assistant at the University of Düsseldorf, Germany, held at the EMBL in Grenoble, France (1.25 years)
    1983-1986. Lister Prize Fellow of the Lister Institute of Preventive Medicine; held at the Kennedy Institute of Rheumatology, London (3.75 years). Honorary memberships of the Laboratory of Molecular Biophysics, Oxford, and the Dept. of Crystallography, Birkbeck College, London.


    Present position (from 1986):

    Wellcome Lecturership in the Department of Biochemistry and Chemistry, Royal Free Hospital School of Medicine, London, in November 1986.

    Promoted to a Wellcome Senior Lecturership in November 1989.

    Promoted to a Readership in Structural Biochemistry in February 1994.

    Promoted to Professor of Structural Biochemistry in July 1998.

    Relocated to the Bloomsbury Campus of University College London in January 2002.


    Promoted to Professor of Structural Biochemistry (Band 2) in November 2008.

  4. Karl Simpson

    Current information Independent, Consultant in Biotech, Bénézech - Simpson Hameau de Bobon VION, France E-mail Nationality: British
    EMBL information Scientist Miller Group GR From 1978 to 1981 Biography Hide biography
    Biography: Graduated in biochemistry from King's College London in 1973. Research King's College Hospital and molecular biology Ph.D programme, Portsmouth Polytechnic. Head of the Deuteration laboratory at EMBL's Grenoble outstation.
    Since 1985 consultant, entrepreneur and president of Bénézech-Simpson.Patents in vaccines. Secretary of the IRDAC biotechnology working party, which helped to structure the EC's Framework Programme for research funding.
    Edited publications in biotechnology (Financial Times, London, UK; Genetic Engineering News, NY, USA; Biotech Forum Europe, Heidelberg, Germany etc). Clients included nations (UK, USA, France, Canada, Malaysia); diagnostics companies (Combio Group, Oxford Glycosciences, Corning); organisations concerned by vaccines (WHO, European Commission) and agencies concerned by chem/biowarfare (government agencies of USA, UK, France, as well as NATO and European Commission). Mainstream pharmaceutical industry (Aventis, GSK), veterinary biotechnology (Boehringer Ingelheim, Germany) or bioengineering (Snamprogetti Biotecnologie, Italy). He was Executive Director of EAPPI (European Association of the Plasma Products Industry) and Vice President of ADEBIO, the French biotech association.
    Since 2001 Karl has been working as a consultant to Ontario's Ministry of Economic Development and Trade, securing inward investment and promoting Ontario's capabilities in the life sciences industry sector. He was the driver of an Ontario-France biotechnology collaboration.
    Karl is a Fellow of: the Institute of Biology, the World Academy of Arts and Sciences, the International Forum for Biophilosophy and the World Technology Network. In 2001 he was a finalist in the Health and Medicine section for the World Technology Award for his work on a thermostable oral polio vaccine.